# Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium

> **NCT00014274** · PHASE2,PHASE3 · COMPLETED · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 238 (actual)

## Conditions studied

- Bladder Cancer
- Transitional Cell Cancer of the Renal Pelvis and Ureter
- Urethral Cancer

## Interventions

- **DRUG:** carboplatin
- **DRUG:** gemcitabine hydrochloride
- **DRUG:** methotrexate
- **DRUG:** vinblastine sulfate

## Key facts

- **NCT ID:** NCT00014274
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-01
- **Primary completion:** 2008-03
- **Final completion:** —
- **Target enrollment:** 238 (ACTUAL)
- **Last updated:** 2013-06-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00014274

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00014274, "Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00014274. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*